Trial intelligence / Profile preview

Pharmacokinetics of orally administered nicotinamide and NAD+ metabolites in healthy adults

jRCTs041190107Completed

Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of nicotinamide (2 arms). Primary endpoint: Pharmacokinetics of NAD+. Started Jan 2020; status: completed.

02

Drugs

nicotinamide

Beyond the preview

Go deeper on jRCTs041190107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041190107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call